Fear of Recurrence and Stopping Immunotherapy
Recruiting
N/A
Interventional Study
Cognitive Behavioral Therapy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 21 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 100 (estimated)
- Sponsor
- University of Pittsburgh · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The study includes participants experiencing distress with regard to stopping immunotherapy and will utilize cognitive-behavioral therapy to reduce fear of recurrence, depression, and anxiety and improve quality of life.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 21 years and older
* Fluent in English
* Diagnosis of cancer and history of treatment with immunotherapy
Exclusion Criteria:
* Active suicidal ideation, delusions or hallucinations
Contacts